To obtain further insights into the molecular differences of disease-specific EV proteomes, we performed an exploratory label-free proteomic analysis of a subset of frontal cortex EV from DLB patients and healthy controls, with and without GBA mutations. The gene discussed is GBA1; the disease is Lewy body dementia.